These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2179608)

  • 1. Protection against Babesia infection in beagles immunized with Toxoplasma lysate antigen.
    Sato M; Igarashi I; Saito A; Hirose T; Suzuki N
    Nihon Juigaku Zasshi; 1990 Feb; 52(1):155-8. PubMed ID: 2179608
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunization with recombinant surface antigen P50 of Babesia gibsoni expressed in insect cells induced parasite growth inhibition in dogs.
    Fukumoto S; Tamaki Y; Shirafuji H; Harakawa S; Suzuki H; Xuan X
    Clin Diagn Lab Immunol; 2005 Apr; 12(4):557-9. PubMed ID: 15817768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination against canine babesiosis.
    Schetters T
    Trends Parasitol; 2005 Apr; 21(4):179-84. PubMed ID: 15780840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination of dogs against heterologous Babesia canis infection using antigens from culture supernatants.
    Schetters TP; Kleuskens JA; Scholtes NC; Gorenflot A; Moubri K; Vermeulen AN
    Vet Parasitol; 2001 Sep; 100(1-2):75-86. PubMed ID: 11522408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a recombinant Babesia canis supernatant antigen that protects dogs against virulent challenge infection.
    Moubri K; Kleuskens J; Van de Crommert J; Scholtes N; Van Kasteren T; Delbecq S; Carcy B; Précigout E; Gorenflot A; Schetters T
    Vet Parasitol; 2018 Jan; 249():21-29. PubMed ID: 29279083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy of Babesia gibsoni culture-derived exoantigens against the challenge infection in dogs.
    Sunaga F; Arai S; Itoh S; Taharaguchi S
    Parasitol Res; 2014 May; 113(5):1681-6. PubMed ID: 24535736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strain variation limits protective activity of vaccines based on soluble Babesia canis antigens.
    Schetters TH; Kleuskens J; Scholtes N; Bos HJ
    Parasite Immunol; 1995 Apr; 17(4):215-8. PubMed ID: 7542765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination of dogs against Babesia canis infection using antigens from culture supernatants with emphasis on clinical babesiosis.
    Schetters TP; Kleuskens JA; Scholtes NC; Pasman JW; Bos HJ
    Vet Parasitol; 1994 Apr; 52(3-4):219-33. PubMed ID: 8073606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive effect of Toxoplasma lysate antigen (TLA) on fatal infection with mouse Piroplasma.
    Ogawa R; Sato M; Hirose T; Suzuki N
    Nihon Juigaku Zasshi; 1985 Apr; 47(2):225-36. PubMed ID: 4010124
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibitory effect of antiserum to surface antigen P50 of Babesia gibsoni on growth of parasites in severe combined immunodeficiency mice given canine red blood cells.
    Fukumoto S; Xuan X; Takabatake N; Igarashi I; Sugimoto C; Fujisaki K; Nagasawa H; Mikami T; Suzuki H
    Infect Immun; 2004 Mar; 72(3):1795-8. PubMed ID: 14977989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. With time changes of T-lymphocytes after Babesia infection in mice pretreated with Toxoplasma lysate antigen.
    Sato M; Sekiguchi S; Miyagami T; Sakurai H; Saito A; Hirose T; Suzuki N
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 May; 264(3-4):435-45. PubMed ID: 3310464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Not peripheral parasitaemia but the level of soluble parasite antigen in plasma correlates with vaccine efficacy against Babesia canis.
    Schetters TP; Scholtes NC; Kleuskens JA; Bos HJ
    Parasite Immunol; 1996 Jan; 18(1):1-6. PubMed ID: 9223150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity against Babesia rossi infection in dogs vaccinated with antigens from culture supernatants.
    Schetters TP; Strydom T; Crafford D; Kleuskens JA; van de Crommert J; Vermeulen AN
    Vet Parasitol; 2007 Mar; 144(1-2):10-9. PubMed ID: 17056181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination of dogs against Babesia canis infection.
    Schetters TP; Kleuskens JA; Scholtes NC; Pasman JW; Goovaerts D
    Vet Parasitol; 1997 Dec; 73(1-2):35-41. PubMed ID: 9477490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Babesia bigemina: immunization with purified rhoptries induces protection against acute parasitemia.
    Machado RZ; McElwain TF; Pancracio HP; Freschi CR; Palmer GH
    Exp Parasitol; 1999 Oct; 93(2):105-8. PubMed ID: 10502474
    [No Abstract]   [Full Text] [Related]  

  • 16. Prime-boost vaccination with plasmid DNA followed by recombinant vaccinia virus expressing BgGARP induced a partial protective immunity to inhibit Babesia gibsoni proliferation in dogs.
    Cao S; Mousa AA; Aboge GO; Kamyingkird K; Zhou M; Moumouni PF; Terkawi MA; Masatani T; Nishikawa Y; Suzuki H; Fukumoto S; Xuan X
    Acta Parasitol; 2013 Dec; 58(4):619-23. PubMed ID: 24338330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical usefulness of antibodies against Babesia gibsoni detected by ELISA with recombinant P50.
    Miyama T; Inokuma H; Itamoto K; Okuda M; Verdida RA; Xuan X
    J Vet Med Sci; 2006 Dec; 68(12):1371-3. PubMed ID: 17213713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Onset and duration of immunity against Babesia canis infection in dogs vaccinated with antigens from culture supernatants.
    Schetters TP; Kleuskens JA; Scholtes NC; van de Crommert J; Krijnen E; Moubri K; Gorenflot A; Vermeulen AN
    Vet Parasitol; 2006 May; 138(1-2):140-6. PubMed ID: 16504401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the culture-derived soluble Babesia canis canis antigens derived from the Polish strains of the parasites.
    Adaszek L; Puchalski A; Dec M; Winiarczyk S
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(6):399-403. PubMed ID: 23242220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of antibodies against Babesia canis in dogs in an endemic area.
    Bobade PA; Oduye OO; Aghomo HO
    Rev Elev Med Vet Pays Trop; 1989; 42(2):211-7. PubMed ID: 2626574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.